We are live on ! Find out more
GP

GLR Partners Portfolio holdings

AUM $215M
This Fund
S&P 500
This Quarter Est. Return
+15.46%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$215M
AUM Growth
+$31.5M
Cap. Flow
+$10M
Cap. Flow %
4.67%
Top 10 Hldgs %
46.18%
Holding
118
New
17
Increased
42
Reduced
37
Closed
7

Top Buys

Rank Stock Value
1
BIL icon
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
+$2.74M
2
ANET icon
Arista Networks
ANET
+$1.68M
3
COWZ icon
Pacer US Cash Cows 100 ETF
COWZ
+$1.33M
4
SPHQ icon
Invesco S&P 500 Quality ETF
SPHQ
+$899K
5
QGRW icon
WisdomTree US Quality Growth Fund
QGRW
+$529K

Top Sells

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$1.58M
2
PGEN icon
Precigen
PGEN
+$1.18M
3
MPWR icon
Monolithic Power Systems
MPWR
+$448K
4
VUG icon
Vanguard Morningstar Growth ETF
VUG
+$335K
5
HCA icon
HCA Healthcare
HCA
+$313K

Sector Composition

Rank Sector Weight
1 Technology 13.28%
2 Communication Services 6.12%
3 Industrials 5.52%
4 Healthcare 5.32%
5 Financials 4.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PEP icon
101
PepsiCo
PEP
$195B
$230K 0.11%
1,699
– –
IJK icon
102
iShares S&P Mid-Cap 400 Growth ETF
IJK
$11B
$230K 0.11%
1,957
-413
-17% -$45.9K
VTEB icon
103
Vanguard Tax-Exempt Bond Index Fund
VTEB
$45.7B
$225K 0.1%
4,443
-682
-13% -$34.3K
CL icon
104
Colgate-Palmolive
CL
$71.9B
$225K 0.1%
+2,450
New +$214K
CSX icon
105
CSX Corp
CSX
$95B
$220K 0.1%
+4,635
New +$209K
NBIS
106
Nebius Group N.V.
NBIS
$58.8B
$219K 0.1%
+794
New +$157K
TFI icon
107
State Street SPDR Nuveen ICE Municipal Bond ETF
TFI
$3.1B
$219K 0.1%
4,781
-2,044
-30% -$93.1K
LUNR icon
108
Intuitive Machines
LUNR
$2.83B
$219K 0.1%
+10,225
New +$287K
REGN icon
109
Regeneron Pharmaceuticals
REGN
$85.9B
$218K 0.1%
350
– –
CVX icon
110
Chevron
CVX
$407B
$207K 0.1%
1,247
-101
-7% -$18.8K
EFA icon
111
iShares MSCI EAFE ETF
EFA
$79.4B
$203K 0.09%
+1,954
New +$201K
AAPL icon
112
CALL
Apple
AAPL
$4.63T
– –
-1,000
Closed -$254K
GD icon
113
General Dynamics
GD
$105B
– –
-909
Closed -$312K
HCA icon
114
HCA Healthcare
HCA
$87.9B
– –
-662
Closed -$313K
IBRX icon
115
ImmunityBio
IBRX
$8.27B
– –
-20,000
Closed -$153K
ICE icon
116
Intercontinental Exchange
ICE
$89.4B
– –
-1,791
Closed -$282K
MPWR icon
117
Monolithic Power Systems
MPWR
$65B
– –
-410
Closed -$448K
VRTX icon
118
Vertex Pharmaceuticals
VRTX
$138B
– –
-3,538
Closed -$1.58M
1 2 3 4
5

Similar funds

COA
Crown Oak Advisors Piedmont, California $215M AUM 6.15% 1-Year Est. Return
KCM
KRS Capital Management Bloomfield, Michigan $215M AUM 69.3% 1-Year Est. Return
KWA
Kellett Wealth Advisors Cincinnati, Ohio $215M AUM 22.03% 1-Year Est. Return
PWM
Peterson Wealth Management Sparks, Nevada $215M AUM 17.58% 1-Year Est. Return
RWM
Riverchase Wealth Management Flower Mound, Texas $215M AUM 14.84% 1-Year Est. Return
NC
Nipun Capital Foster City, California $215M AUM 0.3% 1-Year Est. Return
GCL
Gouws Capital LLC Charlotte, North Carolina $215M AUM 43.89% 1-Year Est. Return
LF
LifeSteps Financial Claremont, California $215M AUM 27.52% 1-Year Est. Return

GLR Partners's Q2 2026 Portfolio in Review

As of Q2 2026, GLR Partners held 118 positions worth $215M, up 17% from $183M the previous quarter. Its ten largest holdings account for 46% of the portfolio.

GLR Partners deployed $10M of net new capital in Q2 2026, opening 17 new positions and adding to 42 existing holdings. Its largest new stake was Arista Networks: 10,705 shares worth $1.82M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 11% a quarter earlier, followed by Communication Services and Industrials.

On the sell side, the largest reduction was Precigen, an estimated $1.18M trimmed.

  • GLR Partners's largest Q2 2026 buy was Arista Networks: 10,705 shares worth $1.82M.
  • GLR Partners added most to State Street SPDR Bloomberg 1-3 Month T-Bill ETF in Q2 2026, an estimated $2.74M increase.
  • GLR Partners's biggest Q2 2026 reduction was Precigen, cutting an estimated $1.18M.
  • GLR Partners fully exited Vertex Pharmaceuticals in Q2 2026, selling an estimated $1.58M.
  • GLR Partners's ten largest holdings make up 46% of its $215M portfolio in Q2 2026.
  • GLR Partners opened 17 new positions and closed 7 in Q2 2026.
  • GLR Partners's portfolio value rose 17% quarter-over-quarter to $215M.

Based on GLR Partners's 13F filing for Q2 2026, filed 27 Jul 2026.